Sort
51,593 grants matching “hepatitis”
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
$522,061Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2018 · MH
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
$522,061Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2020 · MH
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
$522,061Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2019 · MH
TREAT-Mayo
$522,045Vijay H Shah · Mayo Clinic Rochester · U01 · FY2013 · AA
Mechanisms of Insulin Resistance in Man
$522,027Mayo Clinic · R01 · FY2005 · DK
Clinical Project
$521,980David L Thomas · Johns Hopkins University · U19 · FY2025 · AI
Multicell type human liver on chip microphysiological platform to examine CRISPR based gene modulation
$521,867Samira Kiani · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · DK
Bariatric Surgery Clinical Research Consortium
$521,865Bruce M Wolfe · Oregon Health & Science University · U01 · FY2012 · DK
Antiviral pharmacology and adherence in drug users
$521,849Jennifer Justice Kiser · University Of Colorado Denver · R01 · FY2016 · DA
Regulation of Net Hepatic Glucose Uptake in Vivo
$521,839Alan D Cherrington · Vanderbilt University · R01 · FY2006 · DK
Liver Prlr signaling in metabolic adaptation to pregnancy
$521,829Hengjiang Henry Dong · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Mouse Models of Chronic Graft-vs-Host Disease
$521,820Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
$521,784Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip
$521,783Lidong Qin · Methodist Hospital Research Institute · R01 · FY2015 · CA
Lipid Aldehyde and Ethanol Induced Liver Damage
$521,760Dennis Petersen · University Of Colorado Denver · R37 · FY2008 · AA
Hepatic Wnt/LRP6 Regulation of Plasma Lipids
$521,751Arya Mani · Yale University · R01 · FY2016 · HL
HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants
$521,643Marianna K Baum · Florida International University · R01 · FY2008 · DA
Crossing Borders: HIV and Substance use at the Gateway to North America
$521,598Kimberly C Brouwer · University Of California, San Diego · R01 · FY2014 · DA
Understanding mechanisms of liver carcinogenesis following developmental BPA exposure
$521,588Caren Weinhouse · Oregon Health & Science University · R01 · FY2023 · ES
Genome-wide CRISPR screening identifies critical regulators controlling ccRCC lung metastasis
$521,579Qing Zhang · Ut Southwestern Medical Center · R01 · FY2025 · CA
Antiviral pharmacology and adherence in drug users
$521,567Jennifer Justice Kiser · University Of Colorado Denver · R01 · FY2017 · DA
Antiviral pharmacology and adherence in drug users
$521,567Jennifer Justice Kiser · University Of Colorado Denver · R01 · FY2019 · DA
Antiviral pharmacology and adherence in drug users
$521,567Jennifer Justice Kiser · University Of Colorado Denver · R01 · FY2018 · DA
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
$521,557Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2023 · ES
The role of hepatocyte tPA in hepatic VLDL production.
$521,357Ze Zheng · Medical College Of Wisconsin · R01 · FY2022 · HL